Mesoporous silica nanocarrier-mediated delivery of Pt(II)-Ferrocene conjugates for enhanced antitumor activity and toxicity Mitigation.
- DOI
- 10.1016/j.ijpharm.2026.127460
- Published
- 2026 Sep 24
- Container
- International journal of pharmaceutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijpharm.2026.127460,
title = {Mesoporous silica nanocarrier-mediated delivery of Pt(II)-Ferrocene conjugates for enhanced antitumor activity and toxicity Mitigation.},
author = {Navas F and Miguel S and Galindo-Caballero A and Risueño I and Morales V and Sanz R and González Vadillo AM and García-Muñoz RA},
year = {2026},
journal = {International journal of pharmaceutics},
doi = {10.1016/j.ijpharm.2026.127460},
url = {https://doi.org/10.1016/j.ijpharm.2026.127460}
}RIS
TY - JOUR TI - Mesoporous silica nanocarrier-mediated delivery of Pt(II)-Ferrocene conjugates for enhanced antitumor activity and toxicity Mitigation. AU - Navas F AU - Miguel S AU - Galindo-Caballero A AU - Risueño I AU - Morales V AU - Sanz R AU - González Vadillo AM AU - García-Muñoz RA PY - 2026 JO - International journal of pharmaceutics DO - 10.1016/j.ijpharm.2026.127460 UR - https://doi.org/10.1016/j.ijpharm.2026.127460 ER -
APA
F, N., S, M., A, G., I, R., V, M., R, S., AM, G. V., & RA, G. (2026). Mesoporous silica nanocarrier-mediated delivery of Pt(II)-Ferrocene conjugates for enhanced antitumor activity and toxicity Mitigation.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127460
Source records
- pubmed · retrieved 2026-09-26T10:45:47.752Z